Responsable Technique Plateforme KISSfMise à jour le 05/01/2022
Brevets / Publications / Communications
Publications
2021
Robert T, Dock-Bregeon AC, Colas P.
Functional characterization of CDK10 and Cyclin M truncated
variants causing severe developmental disorders
Human Mutation : Manuscript submitted - humu-2021-0054
Oyallon B, Brachet-Botineau M, Logé C, Robert T, Bach S, Ibrahim S, Raoul W,
Croix C, Berthelot P, Guillon J, Pinaud N, Gouilleux F, Viaud-Massuard MC,
Denevault-Sabourin C.
New Quinoxaline Derivatives as Dual Pim-1/2 Kinase Inhibitors: Design, Synthesis
and Biological Evaluation.
Molecules. 2021 Feb 6;26(4):867. doi: 10.3390/molecules26040867.
Princival I, Princival J, da Silva E, Lima S, Carregos J, de Lucenaa A, Halwass F,
Franc J, Ferreir L, Hernandes M, Saraiv K, Peixoto K, Baratte B, Robert T, Bach S,
Gomes D, Paiva D, Marchand P, Rodrigues M and da Silva T. Streptomyces
hygroscopicus UFPEDA 3370: a valuable source of the potent cytotoxic agent
nigericin and its evaluation against human colorectal cancer cells.
Chemico-Biological Interactions.5 janvier 2021; 333: 109316. doi: 10.1016 /
j.cbi.2020.109316
Bazin A, Cojean S, Pagniez F, Bernadat G, Cavé C, Ourliac-Garnier I, Nourrisson
M-R, Morgado C, Picot C, Leclercq O, Baratte B, Robert T, Späth GF, Rachidi N,
Bach S, Loiseau PM, Le Pape P and Marchand P. In vitro identification of
imidazo[1,2-a]pyrazine-based antileishmanial agents and evaluation of L. major
casein kinase 1 inhibition. European Journal of Medicinal Chemistry. 15 janvier
2021; 210: 112956. doi: 10.1016 / j.ejmech.2020.112956
2020
Robert T, Johnson JL, Guichaoua R, Yaron TM, Bach S, Cantley LC, Colas P.
Development of a
CDK10/CycM in vitro Kinase Screening Assay and Identification of First
Small-Molecule Inhibitors.
Front. Chem., 27 February 2020 | https://doi.org/10.3389/fchem.2020.00147
Ibrahim N, Bonnet P, Brion JD, Peyrat JF, Bignon J, Levaique H, Josselin B, Robert
T, Colas P, Bach S, Messaoudi S, Alami M, Hamze A. Identification of a new series
of flavopiridol-like structures as kinase inhibitors with high cytotoxic potency. Eur J
Med Chem. 199:112355. doi: 10.1016/j.ejmech.2020.112355.
Wilde M, Arzur D, Baratte B, Lefebvre D, Robert T, Roisnel T, Le Jossic-Corcos C,
Bach S, Corcos L and Erb W. Regorafenib analogues and their ferrocenic
counterparts: synthesis and biological evaluation. The article was first published on
10 Nov 2020. New J. Chem.10 Nov 2020, https://doi.org/10.1039/D0NJ05334A.